Mobile AI app to predict glucose and suggest insulin bolus doses for people on multiple daily injections
Official title: Evaluation of a Mobile AI-powered Decision Support System for Insulin Dosing and Glucose Prediction in Type 1 Diabetes: The glUCModel Clinical Trial Protocol
Run by Universidad Complutense de Madrid · NCT07304778 · Data updated 2026-11-12
This study will test whether a smartphone AI app can help adults with insulin-requiring diabetes on multiple daily injections predict blood sugar and suggest bolus doses to increase time-in-range and reduce highs and lows.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 34 (estimated) |
| Sponsor | Universidad Complutense de Madrid Academic / other |
| Locations | 2 sites (Madrid, Madrid and 1 other locations) |
| Status | Recruiting |
| Started | July 11, 2025 |
| Main results expected | February 1, 2026 |
| Study ends | June 1, 2026 |
| Registry record updated | January 6, 2026 |
| Trial ID | NCT07304778 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Spanish-speaking adults (18–65) with insulin-requiring diabetes on multiple daily injections, using a CGM, with HbA1c below 9%, at least one year since diagnosis, and able to use a smartphone app and follow portion-controlled diet guidance.
✕Probably not a fit
Patients not on multiple daily injections, not using CGM, non–Spanish speakers, those with poor control (e.g., HbA1c ≥9%), on systemic corticosteroids, with recent hospitalization or major surgery, or with significant psychiatric disorders are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 on multiple daily insulin injections will be screened, complete a 2-week run-in with continuous glucose monitoring (CGM), and then be followed during an active treatment phase where one group uses the glUCModel app in addition to usual care. The app uses personalized predictive models generated from run-in CGM data to provide bolus dosing recommendations and short-term glucose forecasts. Key outcomes include change in time-in-range, frequency of hypoglycaemia and hyperglycaemia, and user-centered measures of app usability and design. Participants must be Spanish-speaking, able to use a smartphone and CGM, and have at least one year since diagnosis.
Why it matters
Potential benefit: If successful, the app could increase the proportion of time patients spend in their glucose target range and reduce episodes of dangerous low and high blood sugar.
How similar studies have gone: Previous small pilots of predictive glucose models and insulin decision-support tools have shown promising improvements in time-in-range and dose guidance, but larger randomized data are still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * HbA1c \< 9% * Currently following an MDI Bolus-Basal therapy. * Wearing CGMs connected to a mobile phone. * Spanish language proficiency. * Willingness to participate in the trial. * At least one year since the time of diabetes diagnosis. * Ability to use a mobile application like glUCModel. * Own a mobile phone running Android or iOS operating system. * Ability to follow a Portion-controlled diet for diabetes. * Educated to do an active management of insulin dosing Exclusion Criteria: * HbA1c \< 9%. * Not wearing CGMs. * Non-Spanish language proficiency. * Less than one year since the time of diabetes diagnosis * Unable to use a mobile application like glUCModel * Unable to follow a Portion-controlled diet for diabetes * Unable to do an active management of insulin dosing. * Diagnosed with a significant psychiatric disorder. * Subjects in treatment with corticoids * Patients who have required hospitalization or surgery in the last six months. * Pregnancy or planning a pregnancy
Where it's running
-
Hospital Universitario de Toledo
Toledo, Toledo, Spain Recruiting -
Universidad Complutense de Madrid
Madrid, Madrid, Spain Not yet recruiting
Study contacts
- Study coordinator: Ignacio Hidalgo, PhD
- Email: hidalgo@dacya.ucm.es
- Phone: +34679562712
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
App-assisted Medical Nutrition Therapy for diabetes with insulin use
This study tests whether using the Undermyfork Care app together with nutrition counseling improves blood sugar, cholesterol, quality of life, activity, and eating choices in adults with type 1 or type 2 diabetes who use insulin.
-
Dexcom G7 CGM in critically ill adults after major abdominal surgery or solid organ transplant
This study tests how accurately the Dexcom G7 continuous glucose monitor tracks glucose in ICU patients after major abdominal surgery or solid organ transplantation who need tight insulin control.
-
Three-stage CGM integration program for older adults with insulin-dependent diabetes
A program with three CGM-focused training sessions is being tested to see if it helps older adults using insulin wear CGMs more and manage their glucose better compared with standard CGM training.
-
MiniMed NMX8 automated insulin delivery system vs 780G in people with diabetes
This study tests whether the new MiniMed NMX8 automated insulin delivery system works safely and performs as well as or better than the existing 780G system in people with insulin-requiring diabetes.
-
Using ultrasound to prevent insulin-related fatty lumps in people with diabetes
This project will try using ultrasound scans in diabetes clinics to find hidden insulin-related fatty lumps (lipohypertrophy) in adults on insulin who use CGM and have variable glucose levels.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.